{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-06-102025-06-101111100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-06-102025-06-101111100
Download SVG
Download PNG
Download CSV

debate over high salaries for bank managers intensifies in switzerland

Sergio Ermotti, UBS's CEO, earned 14.9 million francs last year, making him Europe's highest-paid banking manager, sparking renewed political debate over executive salaries. A recent motion proposes capping bank managers' salaries at 5 million francs, which could hinder talent acquisition in the financial sector. Critics argue that excessive variable pay encourages risky behavior, echoing concerns from past banking crises.

Swiss stock market edges up as Oerlikon and Basilea report strong results

The Swiss stock market closed slightly higher, with the SMI rising 0.15% to 12,893.98 points, buoyed by gains in cyclical and financial stocks. Notable performers included OC Oerlikon (+8.7%) and Basilea (+8.3%), while Lonza (-2.7%) and Siegfried (-6.3%) faced declines due to conservative outlooks. Encouraging economic signals from Germany and the USA contributed to a positive market sentiment.

ubs maintains neutral rating for nestlé shares with target price of 80 francs

UBS AG has maintained a "Neutral" rating for Nestlé shares with a target price of 80 francs, following a recent investor event where management expressed confidence in driving change. As of 17:12, shares were nearly unchanged at CHF 82.40, reflecting a downside risk of 2.91% compared to the target price. Since the start of 2025, the share price has increased by 10%, with Q2 2025 key figures set to be released on July 24, 2025.

ubs maintains neutral rating for nestle with target price of 80 francs

UBS has maintained a "Neutral" rating for Nestlé, setting a target price of 80 francs following a recent investor event. Analyst Guillaume Delmas noted management's confidence and the rapid pace of the company's transformation efforts.

nestle maintains strong market position with diverse product offerings and global reach

Nestlé S.A., the world's leading agribusiness group, generates net sales across various product categories, including powdered and liquid beverages (26.7%), pet food (20.3%), and pharmaceuticals, nutrition, and wellness (16.4%). Geographically, sales are concentrated in the U.S. and Canada (35%), followed by Asia and Oceania (21.4%) and Latin America (13.7%).

ubs rates nestle neutral with target price of 80 francs

UBS has rated Nestlé S.A. as 'Neutral' with a target price of 80 francs. As the largest food group globally, Nestlé's sales are diversified across various sectors, including beverages (26.7%), pet food (20.3%), and pharmaceuticals (16.4%), with significant market presence in the USA and Canada (35%).

barclays highlights cost challenges and slow recovery for nestlé in fiscal year 2025

Nestlé S.A., the world's leading agri-food group, reports net sales across various categories, with powdered and liquid beverages at 26.7%, pet food at 20.3%, and pharmaceutical products at 16.4%. Geographically, 35% of sales come from the U.S. and Canada, followed by Asia and Oceania at 21.4%. The company faces cost pressures and a slow recovery outlook for FY25.

swiss filmmaker richard dindo passes away at 80 in paris hospital

Richard Dindo, the renowned Swiss filmmaker and documentary maker, passed away at the age of 80 in a Paris hospital, surrounded by family. His contributions to cinema have left a lasting impact on the industry. In other news, rents in Switzerland are on the rise, with a 0.2% increase in January and a 3.1% annual growth, driven by significant hikes in low-tax cantons.

market updates shares performance and analyst recommendations in europe and us

UBS shares have been removed from a model portfolio by a strategist, following a recent reinstatement by another analyst. The Swiss market shows mixed performance, with Givaudan gaining slightly while Sonova and Dätwyler face declines. Notable updates include Galderma receiving EMA marketing authorization and Novartis gaining FDA orphan drug designation for Ianalumab.

Swiss stocks rise as easing inflation boosts Nestlé shares and earnings reports

Swiss stocks rose, with the Swiss Market Index up 1.85%, as inflation eased to 0.4% in January. Nestlé shares surged 6.22% after affirming its 2025 growth outlook, despite a 1.8% sales drop in 2024. Conversely, Swisscom's stock fell 3.04% following a 9.9% decline in net income due to acquisition costs.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Machinary - Dashboard

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.